CervoMed (CRVO) Return on Sales [ROS] (2009 - 2026)
CervoMed (CRVO) posted Return on Sales [ROS] of -9406.96% for Q2 2026, down 9030.55 percentage points from -376.41% a year earlier and down 7918.10 percentage points from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
For FY2025, CervoMed's Return on Sales [ROS] came in at -706.22%, down 519.05 percentage points from FY2024.
- In prior years, CervoMed's Return on Sales [ROS] was -187.18% in FY2024 (-77.83 pp) and -109.35% in FY2023.
- Quarterly Return on Sales [ROS] has run from a low of -95479.25% in Q4 2025 to a high of -71.57% in Q2 2023 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last ten quarters, with an average year-over-year change of -13549.05 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2023, with a gain of 18201.35 percentage points; the weakest was Q4 2025, with a drop of 95144.33 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -1488.86% (Q1 2026), -95479.25% (Q4 2025) and -2493.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | CervoMed | 20.73 Mn | -57.60 Mn | - | -334,924.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -334,924.87% |
| Jun 30, 2026 | -9,406.96% |
| Mar 31, 2026 | -1,488.86% |
| Dec 31, 2025 | -95,479.25% |
| Sep 30, 2025 | -2,493.79% |
| Jun 30, 2025 | -376.41% |
| Mar 31, 2025 | -276.55% |
| Dec 31, 2024 | -334.91% |
| Sep 30, 2024 | -278.19% |
| Jun 30, 2024 | -91.06% |
| Mar 31, 2024 | -110.55% |
| Dec 31, 2023 | -99.59% |
| Sep 30, 2023 | -175.25% |
| Jun 30, 2023 | -71.57% |
| Mar 31, 2023 | -101.31% |
| Dec 31, 2022 | -12,794.31% |
| Sep 30, 2022 | -17,720.61% |
| Jun 30, 2022 | -7,667.09% |
| Mar 31, 2022 | -16,377.61% |
| Dec 31, 2021 | -17,948.68% |
API Access
CervoMed Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();